On October 23, the Committee on Oversight of the House of Representatives of the US Congress began to study the deal concluded during President Obama between Rosatom's subsidiary Atomredmetzoloto (ARMZ) and Canadian Uranium One. In 2009, the subsidiary received a 16.6% stake in the Canadian company entitled to extract uranium in the United States.